![discount label](https://static.cymitquimica.com/public/img/discount.png)
4-[(4-Chlorophenyl)amino]-4-oxobutanoic acid
CAS: 17722-52-0
Ref. 3D-FC126496
1g | A consultar | ||
2g | A consultar | ||
5g | A consultar | ||
10g | A consultar | ||
500mg | A consultar |
Información del producto
- butanoic acid
- 4-[(4-chlorophenyl)amino]-4-oxo-
- Butanoic Acid, 4-[(4-Chlorophenyl)Amino]-4-Oxo-
4-[(4-Chlorophenyl)amino]-4-oxobutanoic acid is a hydroxylated metabolite of ocrelizumab, a humanized monoclonal antibody that targets CD20. 4-[(4-Chlorophenyl)amino]-4-oxobutanoic acid inhibits the proliferation of lymphocytes and macrophages, which is caused by its ability to inhibit the production of proinflammatory cytokines. This drug has been shown to be effective for the treatment of autoimmune diseases such as multiple sclerosis, rheumatoid arthritis, and Crohn’s disease. It also has beneficial effects on body mass index and disease activity in patients with these diseases.
Propiedades químicas
Consulta técnica sobre: 3D-FC126496 4-[(4-Chlorophenyl)amino]-4-oxobutanoic acid
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.